Publicacions científiques | Siidon | Guttmann

Cercador

Article

Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple Sclerosis.

Autor/s:

Foley JF, Defer G, Ryerson LZ, Cohen JA, Arnold DL, Butzkueven H, Cutter GR, Giovannoni G, Killestein J, Wiendl H, Li K, Dsilva L, Toukam M, Ferber K, Sohn J, Engelman H, Lasky T.

Any publicació:

2024

Número de revista:

Neurology Neuroimmunology & Neuroinflammation vol. 11 n. 6

https://www.neurology.org/doi/full/10.1212/NXI.0000000000200321

Article

Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy.

Autor/s:

Foley AR, Yun P, Leach ME, Neuhaus SB, Averion GV, Hu Y, Hayes LH, Donkervoort S, Jain MS, Waite M, Parks R, Bharucha-Goebel DX, Mayer OH, Zou Y, Fink M, DeCoster J, Mendoza C, Arévalo C, Hausmann R, Petraki D, Cheung K, Bönnemann CG.

Any publicació:

2024

Número de revista:

Neurology® Genetics. vol. 10 n. 3

https://www.neurology.org/doi/full/10.1212/NXG.0000000000200164

Phenoconversion in Women and Men With Isolated REM Sleep Behavior Disorder: A Retrospective Cohort Study.

Autor/s:

Alexandres CA, McCarter SJ, Tabatabai GM, LeClair-Visonneau L, Feemster JC, Gossard TR, Strainis EP, Jagielski JT, Kelleher MR, Finstuen T, Ali F, Botha H, Graff-Radford J, Olson EJ, Sandness DJ, Morgenthaler TJ, Kantarci K, Savica R, Singer W, Covassin N, Somers VK, Kirkland JL, Junna M, Lipford M...

Clinical/Scientific Notes

Any publicació:

2024

Número de revista:

Neurology vol. 103 n. 10

https://www.neurology.org/doi/full/10.1212/WNL.0000000000209993

Article

Phenotypic Insights Into Anti-IgLON5 Disease in IgLON5-Deficient Mice.

Autor/s:

Lee SY, Shoji H, Shimozawa A, Aoyagi H, Sato Y, Tsumagari K, Terumitsu M, Motegi H, Okada K, Sekiguchi K, Kuromitsu J, Nakahara J, Miyakawa T, Ito D.

Any publicació:

2024

Número de revista:

Neurology Neuroimmunology & Neuroinflammation vol. 11 n. 3

https://www.neurology.org/doi/full/10.1212/NXI.0000000000200227

Article

Phosphodiesterase Type 5 Inhibitors in Men With Erectile Dysfunction and the Risk of Alzheimer Disease: A Cohort Study.

Autor/s:

Adesuyan M, Jani YH, Alsugeir D, Howard R, Ju C, Wei L, Brauer R.

Any publicació:

2024

Número de revista:

Neurology vol. 102 n. 4

https://www.neurology.org/doi/full/10.1212/WNL.0000000000209131

Article

Physical Activity and Life Stress Are Associated With Illness Intrusiveness in Persons With Multiple Sclerosis.

Autor/s:

Gromisch ES, Neto LO, DelMastro HM, Dhari Z, Pisa M, Turner AP.

Any publicació:

2024

Número de revista:

Archives of Physical Medicine and Rehabilitation. vol. 105 n. 5

https://www.sciencedirect.com/science/article/pii/S0003999323006457

Physical Activity as a Risk Factor for Amyotrophic Lateral Sclerosis.

Autor/s:

Shaw PJ, Cooper-Knock J.

Editorial

Any publicació:

2024

Número de revista:

Neurology vol. 103 n. 2

https://www.neurology.org/doi/full/10.1212/WNL.0000000000209580

Physical Activity for Persons with Intellectual and Developmental Disabilities: A Support Guide for Health Care Professionals.

Autor/s:

Santos FH, Sood P, Gan DRY, Lansang N, Devos H, Heyn PC.

Information/Education Page

Any publicació:

2024

Número de revista:

Archives of Physical Medicine and Rehabilitation. vol. 105 n. 5

https://www.sciencedirect.com/science/article/pii/S000399932300518X

Article de revisió

PHYSICAL ACTIVITY MEASUREMENT IN PEOPLE WITH SPINAL CORD INJURY: A COMPARATIVE REVIEW OF DIFFERENT QUESTIONNAIRES

Autor/s:

Úbeda-Colomer J, Castan A.

Any publicació:

2024

https://www.mdpi.com/2077-0383/13/22/6997

Article

Physical Activity, Fitness, and Long-Term Risk of Amyotrophic Lateral Sclerosis: A Prospective Cohort Study.

Autor/s:

Vaage AM, Meyer HE, Landgraff IK, Myrstad M, Holmøy T, Nakken O.

Any publicació:

2024

Número de revista:

Neurology vol. 103 n. 2

https://www.neurology.org/doi/full/10.1212/WNL.0000000000209642